Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study
Crossref DOI link: https://doi.org/10.1186/s12885-015-1746-3
Published Online: 2015-10-14
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rahal, S.
Boher, J M
Extra, J M
Tarpin, C.
Charafe-Jauffret, E.
Lambaudie, E.
Sabatier, R.
Thomassin-Piana, J.
Tallet, A.
Resbeut, M.
Houvenaeghel, G.
Laborde, L.
Bertucci, F.
Viens, P.
Gonçalves, A.
License valid from 2015-10-14